The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Interferon‐regulated chemokines as biomarkers of systemic lupus erythematosus disease activity: A validation study
Open accessAbstract
Objective: Systemic lupus erythematosus (SLE) is a complex autoimmune disease characterized by unpredictable flares of disease activity and irreversible damage to multiple organ systems. An earlier study showed that SLE patients carrying an interferon (IFN) gene expression signature in blood have elevated serum levels of IFN‐regulated chemokines. These chemokines were associated with more‐severe and active disease and showed promise as SLE disease activity biomarkers. This study was designed to validate IFN‐regulated chemokines as biomarkers of SLE disease activity in 267 SLE patients followed up longitudinally. Methods: To validate the potential utility of serum chemokine levels as biomarkers of disease activity, we measured serum levels of CXCL10 (IFNγ‐inducible 10‐kd protein), CCL2 (monocyte chemotactic protein 1), and CCL19 (macrophage inflammatory protein 3β) in an independent cohort of 267 SLE patients followed up longitudinally over 1 year (1,166 total clinic visits). Results: Serum chemokine levels correlated with lupus activity at the current visit ( P = 2 × 10 −10 ), rising at the time of SLE flare ( P = 2 × 10 −3 ) and decreasing as disease remitted ( P = 1 × 10 −3 ); they also performed better than the currently available laboratory tests. Chemokine levels measured at a single baseline visit in patients with a Systemic Lupus Erythematosus Disease Activity Index of ≤4 were predictive of lupus flare over the ensuing year ( P = 1 × 10 −4 ). Conclusion: Monitoring serum chemokine levels in SLE may improve the assessment of current disease activity, the prediction of future disease flares, and the overall clinical decision‐making.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cluster analysis and display of genome-wide expression patterns
Eisen, M. B., Spellman, P. T., Brown, P. O., & Botstein, D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.25.14863 · Cited by 16,184
Derivation of the sledai. A disease activity index for lupus patients
Bombardier, C., Gladman, D. D., Urowitz, M. B., Caron, D., Chang, C. H., Austin, A., Bell, A., Bloch, D. A., Corey, P. N., Decker, J. L., et al. (1992) · Arthritis & Rheumatism · doi:10.1002/art.1780350606 · Cited by 4,570
Baechler, E. C., Batliwalla, F. M., Karypis, G., Gaffney, P. M., Ortmann, W. A., Espe, K. J., Shark, K. B., Grande, W. J., Hughes, K. M., Kapur, V., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0337679100 · Cited by 2,240
Self-citationInterferon and Granulopoiesis Signatures in Systemic Lupus Erythematosus Blood
Bennett, L., Palucka, A. K., Arce, E., Cantrell, V., Borvak, J., Banchereau, J., & Pascual, V. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021553 · Cited by 1,958
TYPE I INTERFERONS (α/β) IN IMMUNITY AND AUTOIMMUNITY
Theofilopoulos, A. N., Baccala, R., Beutler, B., & Kono, D. H. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115843 · Cited by 1,185
Kirou, K. A., Lee, C., George, S., Louca, K., Peterson, M. G. E., & Crow, M. K. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21031 · Cited by 701
Graham, R. R., Kozyrev, S. V., Baechler, E. C., Reddy, M. V. P. L., Plenge, R. M., Bauer, J. W., Ortmann, W. A., Koeuth, T., Escribano, M. F. G., Collaborative Groups, T. A. A. S., et al. (2006) · Nature Genetics · doi:10.1038/ng1782 · Cited by 671
Self-citationBuyon, J. P., Petri, M. A., Kim, M. Y., Kalunian, K. C., Grossman, J., Hahn, B. H., Merrill, J. T., Sammaritano, L., Lockshin, M., Alarcón, G. S., et al. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-142-12_part_1-200506210-00004 · Cited by 661
Self-citationGraham, R. R., Kyogoku, C., Sigurdsson, S., Vlasova, I. A., Davies, L. R. L., Baechler, E. C., Plenge, R. M., Koeuth, T., Ortmann, W. A., Hom, G., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0701266104 · Cited by 450
Self-citationCoordinate overexpression of interferon‐α–induced genes in systemic lupus erythematosus
Kirou, K. A., Lee, C., George, S., Louca, K., Papagiannis, I. G., Peterson, M. G. E., Ly, N., Woodward, R. N., Fry, K. E., Lau, A. Y., et al. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20798 · Cited by 418
Petri, M., Genovese, M., Engle, E., & Hochberg, M. (1991) · Arthritis & Rheumatism · doi:10.1002/art.1780340802 · Cited by 340
Self-citationBauer, J. W., Baechler, E. C., Petri, M., Batliwalla, F. M., Crawford, D., Ortmann, W. A., Espe, K. J., Li, W., Patel, D. D., Gregersen, P. K., et al. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030491 · Cited by 313
Self-citationType I interferon correlates with serological and clinical manifestations of SLE
Dall’Era, M., Cardarelli, P. M., Preston, B. T., Witte, A., & Davis, J. C. (2005) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2004.033753 · Cited by 289
Rönnblom, L., & Alm, G. V. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.12.f59 · Cited by 288
Ehrlich, G. E. (2002) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.288.2.251 · Cited by 261
VALLIN, H., BLOMBERG, S., ALM, G. V., CEDERBLAD, B., & RÖNNBLOM, L. (2001) · Clinical and Experimental Immunology · doi:10.1046/j.1365-2249.1999.00772.x · Cited by 252
Wenzel, J., Wörenkämper, E., Freutel, S., Henze, S., Haller, O., Bieber, T., & Tüting, T. (2005) · The Journal of Pathology · doi:10.1002/path.1721 · Cited by 247
Meller, S., Winterberg, F., Gilliet, M., Müller, A., Lauceviciute, I., Rieker, J., Neumann, N. J., Kubitza, R., Gombert, M., Bünemann, E., et al. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21034 · Cited by 244
Predictive value of complement profiles and anti-dsDNA in systemic lupus erythematosus.
Swaak, A. J., Groenwold, J., & Bronsveld, W. (1986) · Annals of the Rheumatic Diseases · doi:10.1136/ard.45.5.359 · Cited by 224
The emerging role of interferon in human systemic lupus erythematosus
Baechler, E. C., Gregersen, P. K., & Behrens, T. W. (2004) · Current Opinion in Immunology · doi:10.1016/j.coi.2004.09.014 · Cited by 212
Self-citationValidity and reliability of lupus activity measures in the routine clinic setting.
Petri, M., Hellmann, D. B., & Hochberg, M. C. (1992) · PubMed · Cited by 204
Self-citationLit, L. C. W., Wong, C. K., Tam, L. S., Li, E. K. M., & Lam, C. W. K. (2006) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2005.038315 · Cited by 181
Esdaile, J. M., Abrahamowicz, M., Joseph, L., MacKenzie, T., Li, Y., & Danoff, D. (1996) · Arthritis & Rheumatism · doi:10.1002/art.1780390304 · Cited by 177
Biomarkers in systemic lupus erythematosus: II. Markers of disease activity
Illei, G. G., Tackey, E., Lapteva, L., & Lipsky, P. E. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20345 · Cited by 141
SERUM LEVELS OF IFN-INDUCIBLE PROTEIN-10 RELATING TO THE ACTIVITY OF SYSTEMIC LUPUS ERYTHEMATOSUS
Narumi, S., Takeuchi, T., Kobayashi, Y., & Konishi, K. (2000) · Cytokine · doi:10.1006/cyto.2000.0757 · Cited by 126
Petri, M. (2000) · Rheumatic Disease Clinics of North America · doi:10.1016/s0889-857x(05)70135-6 · Cited by 121
Self-citationBiomarkers for systemic lupus erythematosus: a review and perspective
Liu, C., Manzi, S., & Ahearn, J. M. (2005) · Current Opinion in Rheumatology · doi:10.1097/01.bor.0000174182.70159.22 · Cited by 70
Clinically active serologically quiescent systemic lupus erythematosus.
Gladman, D. D., Hirani, N., Ibañez, D., & Urowitz, M. B. (2003) · PubMed · Cited by 50
Schiffenbauer, J., Hahn, B., Weisman, M. H., & Simon, L. S. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20353 · Cited by 36
Ho (2001) · Pure Amsterdam UMC · doi:10.1002/1529-0131(200110)44:10 · Cited by 3
Cited by
CXCR3 ligands: redundant, collaborative and antagonistic functions
Groom, J. R., & Luster, A. D. (2011) · Immunology & Cell Biology · doi:10.1038/icb.2010.158 · Cited by 1,001
Groom, J. R., & Luster, A. D. (2011) · Experimental Cell Research · doi:10.1016/j.yexcr.2010.12.017 · Cited by 988
Type I Interferon in the Pathogenesis of Lupus
Crow, M. K. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1002795 · Cited by 561
Taming lupus-a new understanding of pathogenesis is leading to clinical advances
Liu, Z., & Davidson, A. (2012) · Nature Medicine · doi:10.1038/nm.2752 · Cited by 433
Chiche, L., Jourde‐Chiche, N., Whalen, E., Presnell, S., Gersuk, V., Dang, K., Anguiano, E., Quinn, C., Burtey, S., Berland, Y., et al. (2014) · Arthritis & Rheumatology · doi:10.1002/art.38628 · Cited by 420
Metadata
- Authors
- Bauer, J. W., Petri, M., Batliwalla, F. M., Koeuth, T., Wilson, J., Slattery, C., Panoskaltsis‐Mortari, A., Gregersen, P. K., Behrens, T. W., & Baechler, E. C.
- Venue
- Arthritis & Rheumatism
- Publisher
- Wiley
- Published
- 2009-09-29
- Volume
- 60
- Issue
- 10
- Pages
- 3098-3107
- ISSN
- 0004-3591 (ISSN-L)
- 1529-0131
- OpenAlex
- W2127198764
- Cited by
- 297
- References
- 30
- FWCI
- 15.01
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.